Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) EPS (Basic) (2022 - 2026)

Envoy Medical's EPS (Basic) history spans 5 years, with the latest figure at -$0.08 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 72.41% to -$0.08 in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.01, a 26.28% increase, with the full-year FY2025 number at -$1.23, up 17.45% from a year prior.
  • EPS (Basic) hit -$0.08 in Q1 2026 for Envoy Medical, up from -$0.26 in the prior quarter.
  • Over the last five years, EPS (Basic) for COCH hit a ceiling of $0.23 in Q1 2022 and a floor of -$1.31 in Q2 2023.
  • Historically, EPS (Basic) has averaged -$0.29 across 5 years, with a median of -$0.29 in 2024.
  • The widest YoY moves for EPS (Basic): up 200.0% in 2023, down 2283.33% in 2023.
  • Tracing COCH's EPS (Basic) over 5 years: stood at -$1.13 in 2022, then surged by 92.92% to -$0.08 in 2023, then crashed by 400.0% to -$0.4 in 2024, then soared by 35.0% to -$0.26 in 2025, then soared by 69.23% to -$0.08 in 2026.
  • Business Quant data shows EPS (Basic) for COCH at -$0.08 in Q1 2026, -$0.26 in Q4 2025, and -$0.35 in Q3 2025.